Risk Mitigation through Early Intervention

Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD) are rapidly growing problems.  Twenty million Americans -- 1 out of every 9 adults -- have Chronic Kidney Disease and another 20 million are at increased risk.

Through predictive modeling and proactive outreach, Tethys reduces the incidence of ESRD, and improves the quality of life for CKD patients.

The Tethys CKD program manages and mitigates the costs associated with common CKD co-morbidities:

• Diabetes
• Hypertension
• Heart Disease
• Other costly chronic conditions

In addition our services delay the onset of End Stage Renal Disease, one of the most expensive conditions for which health plans provide coverage.

There are significant cost savings and improved quality of care with the interventions and management of CKD patients

• Delayed disease progression
• Prolonged period before initiating renal replacement therapy
• Planned vs. urgent vascular access placement
• Mitigation of impact of co-morbid conditions
• Increased selection of peritoneal dialysis over hemodialysis (approximately 30% savings)